Form 4: Coeptis Therapeutics Holdings CTO Receives Stock Grant
Insider Transaction (Form 4)
Jeffery Keeslar Harris, Chief Technology Officer of Coeptis Therapeutics Holdings, Inc., received 100,000 shares of common stock on October 2, 2026.
Summary
- Grant/award: acquired 100,000 Stock Option (Right to Buy) on October 2, 2026; holds 100,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jeffery Keeslar Harris — Officer (Chief Technology Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Grant/award | Stock Option (Right to Buy) | 100,000 | — | — | 100,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Grant/award (100,000 shares) |
Keywords
insider transaction, Form 4, ZSQR, Z Squared Inc., neutral, Jeffery Keeslar Harris
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.